高级检索
    潘燚, 谭佩欣. 一线阿法替尼与化疗对EGFR突变伴有脑转移的非小细胞肺癌患者的疗效评价[J]. 循证医学, 2016, 16(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2016.04.012
    引用本文: 潘燚, 谭佩欣. 一线阿法替尼与化疗对EGFR突变伴有脑转移的非小细胞肺癌患者的疗效评价[J]. 循证医学, 2016, 16(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2016.04.012
    shu
    PAN Yi, TAN Pei-xin. First-Line Afatinib Versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2016.04.012
    Citation: PAN Yi, TAN Pei-xin. First-Line Afatinib Versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases[J]. Journal of Evidence-Based Medicine, 2016, 16(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2016.04.012
    shu

    一线阿法替尼与化疗对EGFR突变伴有脑转移的非小细胞肺癌患者的疗效评价

    First-Line Afatinib Versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

      摘要
      • HTML全文
      • 参考文献(10)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回